Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Piero Ruscitti and Paola Cipriani.
Piero Ruscitti
Connection Strength
1.244
Paola Cipriani
  1. Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders. Adv Rheumatol. 2021 07 08; 61(1):45.
    View in: PubMed
    Score: 0.239
  2. Response to: 'Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al' by Chen et al. Ann Rheum Dis. 2020 Sep 09.
    View in: PubMed
    Score: 0.225
  3. Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences. Ann Rheum Dis. 2020 09; 79(9):1152-1155.
    View in: PubMed
    Score: 0.223
  4. Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm. Front Immunol. 2020; 11:1130.
    View in: PubMed
    Score: 0.221
  5. Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? Ann Rheum Dis. 2020 11; 79(11):1515-1516.
    View in: PubMed
    Score: 0.221
  6. Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis. Clin Exp Rheumatol. 2020 Nov-Dec; 38(6):1247-1254.
    View in: PubMed
    Score: 0.057
  7. The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection. Expert Rev Clin Immunol. 2020 12; 16(12):1205-1215.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.